SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001193125-20-266442
Filing Date
2020-10-08
Accepted
2020-10-08 17:30:28
Documents
5

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 9813
2 GRAPHIC g37315g1007143256630.jpg GRAPHIC 2850
3 GRAPHIC g37315g1007144516198.jpg GRAPHIC 2177
4 GRAPHIC g37315g1007145335208.jpg GRAPHIC 5232
5 GRAPHIC g37315g1007145359809.jpg GRAPHIC 1235
  Complete submission text file 0001193125-20-266442.txt   27184
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations